Celltrion
068270.KS
#859
Rank
NZ$48.56 B
Marketcap
NZ$222.57
Share price
2.41%
Change (1 day)
25.25%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): NZ$3.22

According to Celltrion 's latest financial reports the company's current EPS (TTM) is NZ$3.19. an increase over its 2024 EPS that were of NZ$2.07.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025NZ$5.46163.66%
2024NZ$2.07-53.73%
2023NZ$4.48-2.08%
2022NZ$4.57-11.72%
2021NZ$5.182.03%
2020NZ$5.0882.8%
2019NZ$2.7818.31%
2018NZ$2.35-36.33%
2017NZ$3.69161.25%
2016NZ$1.412.86%
2015NZ$1.3717.84%
2014NZ$1.165.87%
2013NZ$1.10-70.85%
2012NZ$3.77134.09%
2011NZ$1.6143.59%
2010NZ$1.1274.49%
2009NZ$0.64317.8%
2008NZ$0.15-71.7%
2007NZ$0.54